Clinical Study on Yiyun Materia Medica Yin in Auxiliary Improving Ovarian Function

Abstract

Abstract: Objective To evaluate the auxiliary effect of Yiyun Materia Medica Yin in improving the ovarian reserve, so as to provide a way for early treatment of DOR. Methods A total of 64 subjects with diminished ovarian reserve who were recruited were enrolled in this study from August 2020 to April 2021.They were assigned to two groups: the experimental group and the control group, according to the sequence, with 32 cases in each group. The trail continued twelve weeks. After the trail,the sex hormone levels, number of bilateral sinus follicles, sexual life indicators, menstrual indicators and symptom and sign scores of the two groups of subjects were compared between the two groups before and after treatment. Result Before the trail, there was no significant difference in all indicators between the two groups(P>0.05). After the trail, the FSH in the experimental group was lower than before, and the scores of AFC, AMH, sexual life indicators, symptoms and signs were improved compared with at the begining of the trail. The FSH, sexual life indicators, symptoms and signs were significantly different from those in the control group after the trail (P<0.05). Conclusion Yiyun Materia Medica Yin can effectively improve the decreased ovarian reserve, and the safety is good.

Key words: decreased ovarian reserve, Yiyun Materia Medica Yin, clinical research

CLC Number:

R271

KOU Qiu-ai, XIA Li-ying, WANG Wen qian, YANG Jia-xi, SUN Wen-ting, Zhang Ying, YUAN Jing-quan, YANG Yi-ting. Clinical Study on Yiyun Materia Medica Yin in Auxiliary Improving Ovarian Function[J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(16): 1-4.

References

[1] 卵巢储备功能减退临床诊治专家共识[J].生殖医学杂志,2022,31(4):425-434.
[2] TACHIBANA M, KUNO T, YAEGASHI N.Mitochondrial replacement therapy and assisted reproductive technology:a paradigm shift toward treatment of genetic diseases in gametes or in early embryos[J]. Reprod Med Biol,2018,17(4):421-433.
[3] KRISTENSEN S G, PORS S E, ANDERSEN C Y.Improving oocyte quality by transfer of autologous mitochondria from fully grown oocytes[J].Hum Reprod,2017,32(4):725-732.
[4] YU R, JIN H, HUANG X, et al.Comparison of modified agonist, mild-stimulation and antagonist protocols for in vitro fertilization in patients with diminished ovarian reserve[J]. J Int Med Res,2018,46(6):2327-2337.
[5] 安东,刘丽敏.补肾类中成药治疗卵巢储备功能下降的Meta分析[J].中国老年学杂志,2021,41(20):4425-4431.
[6] WEI M, MAHADY G B, LIU D, et al.Astragalin, a Flavonoid from Morus alba (Mulberry) Increases Endogenous Estrogen and Progesterone by Inhibiting Ovarian Granulosa Cell Apoptosis in an Aged Rat Model of Menopause[J]. Molecules,2016,21(5):675.
[7] 蔡妙婷,刘雯,袁源见,等.覆盆子中几种黄酮类成分活性研究进展[J].实用中西医结合临床,2020,20(4):179-182.
[8] 王金金,毋启桐,时博,等.小茴香炮制历史沿革、化学成分及药理作用研究进展[J].中国实验方剂学杂志,2020,26(20):178-190.
[9] 曹泽毅. 中华妇产科学(第3版)(下册)[M].北京:人民卫生出版社,2014:4382-4387.
[10] 杨文文,杨琪,崔楠,等.补肾法治疗卵巢储备功能下降随机对照研究文献的系统评价[J].中国中医基础医学杂志,2021,27(6):978-985.
[11] 熊仪,马文君,霍少川,等.补肾调癸方治疗卵巢储备功能减退的临床研究[J].广州中医药大学学报,2022,39(6):1300-1305.
[12] 向罗珺,金子涵,申玉华,等.补肾调周法治疗肾虚血瘀型卵巢储备功能下降的临床观察[J].实用内科学志,2022,36(8):103-106.
[13] 李善霞,何东云,张艳红,等.补肾养血方治疗肾阴虚型卵巢储备功能下降的临床观察[J].中华中医药学刊,2019,37(2):361-364.
[14] 国家药典委员会.中华人民共和国药典[M].一部.北京:中国医药科技出版社,2020:313.
[15] 刘莹,覃骊兰,蓝毓营.桑葚化学成分、药理作用及质量标志物研究进展[J].重庆医学,2021,50(6):1063-1067.
[16] 黄长盛,贺守第,管雁丞,等.菟丝子黄酮和槲皮素对雷公藤多苷致卵巢早衰大鼠卵巢功能的影响[J].中国临床药理学杂志,2020,36(6):667-670.
[17] 曹圣,热增才旦,李永平,等.覆盆子益精理论的转化应用[J].转化医学电子杂志,2018,5(5):52-55.
[18] LUNDING S A, AKSGLAEDE L, ANDERSON R A, et al.AMH as predictor of premature ovarian insufficiency:A longitudinal study of 120 Turner Syndrome patients[J]. J Clin Endocrinol Metab, 2015, 100(7):E1030-1038.

Related Articles 15

[1]	LV Dan-dan, WANG Si-hai, FANG Zhao-hui. Professor Fang Chaohui's Experience in Treating Menstrual Migraine [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(9): 163-166.
[2]	YU Li-ping. Effect Analysis of Shengdi Point Balancing Acupuncture Combined with Manipulation Massage and Bioelectric Stimulation of Postpartum Pelvic Floor Dysfunction [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(3): 25-28.
[3]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(3): 53-56.
[4]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(23): 41-43.
[5]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(22): 37-40.
[6]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(20): 80-83.
[7]	ZHU Meng-yan, WANG Si-hai, FANG Zhao-hui. Fang Zhaohui's Experience in Treating Perimenopausal Hyperhidrosis Based on Nourishing Yin and Lowering Fire [J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(19): 170-173.
[8]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(19): 176-179.
[9]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(11): 35-37.
[10]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(3): 28-31.
[11]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(23): 59-61.
[12]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(14): 27-30.
[13]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(5): 25-27.
[14]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(4): 5-6.
[15]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(2): 11-13.